Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients

Translational Research

Volumn 152, Issue 2, 2008, Pages 67-80

  Bao, Bin ^a   Prasad, Ananda S ^a   Beck, Frances W J ^a   Snell, Diane ^a   Suneja, Anupam ^a   Sarkar, Fazlul H ^a   Doshi, Nimisha ^a   Fitzgerald, James T ^a   Swerdlow, Paul ^a  

^a Division of Hematology Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; NITRITE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ZINC;

ADULT; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HELPER CELL; HEMATOCRIT; HUMAN; INCIDENCE; INFECTION; LIPID PEROXIDATION; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 50949093099     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.06.001     Document Type: Article

References (53)

1. Prasad A.S., Miale A., Farid Z., Sandstead H.H., and Schulert A.R. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, and dwarfism. J Lab Clin Med 61 (1963) 537-549
2. Prasad A.S. Biochemistry of zinc (1993), Plenum, New York
3. Prasad A.S., Schoomaker E.B., Ortega J., Brewer G.J., Oberleas D., and Oeshlegel F.J. Zinc deficiency in sickle cell disease. Clin Chem 21 (1975) 582-587
4. Prasad A.S., and Cossack Z.T. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 100 (1984) 367-371
5. Prasad A.S., Abbasi A.A., Rabbani P., and DuMouchelle E. Effect of zinc supplementation on serum testosterone level in adult male sickle cell anemia subjects. Am J Hematol 10 (1981) 119-127
6. Warth J.A., Prasad A.S., Zwas F., and Frank R.N. Abnormal dark adaptation in sickle cell anemia. J Lab Clin Med 98 (1981) 189-194
7. Ballester O.F., Abdallah J.M., and Prasad A.S. Lymphocyte subpopulation abnormalities in sickle cell anemia. Am J Hematol 21 (1986) 23-27
8. Prasad A.S., Meftah S., Abdallah J., et al. Serum thymulin in human zinc deficiency. J Clin Invest 82 (1988) 1202-1210
9. Niell H.B., Leach B.E., and Kraus A.P. Zinc metabolism in sickle cell anemia. JAMA 242 (1979) 2686-2687
10. Prasad A.S., Ortega J., Brewer G.J., Oberleas D., and Schoomaker E.B. Trace elements in sickle cell disease. JAMA 235 (1976) 2396-2398
11. Tapazoglou E., Prasad A., Hill G., Brewer G.J., and Kaplan J. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. J Lab Clin Med 105 (1985) 11-22
12. Beck F.W.J., Kaplan J., Fine N., Handschu W., and Prasad A. Decreased expression of CD73 (Ecto-5-nucleotidase) in the CD8+ subset is associated with zinc deficiency in humans. J Lab Clin Med 130 (1997) 147-156
13. Karayalcin G., Lanzkowsky P., and Kazi A.B. Zinc deficiency in children with sickle cell disease. Am J Pediatr Hematol Oncol 1 (1979) 283-284
14. Finan A.C., Elmer M.A., Sasanow S.R., McKinney S., Russell M.O., and Gill F.M. Nutritional factors and growth in children with sickle cell disease. Am J Dis Child 142 (1988) 237-240
15. Phebus C.K., Maciak B.J., Gloninger M.F., and Paul H.S. Zinc status of children with sickle cell disease: relationship to poor growth. Am J Hematol 29 (1988) 67-73
16. Prasad A.S., Beck F.W., Kaplan J., et al. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol 61 (1999) 194-202
17. Raghupathy R., Haider M.Z., Azizieh F., Abdelsalam R., D'Souza T.M., and Adekile A.D. Th1 and Th2 cytokine profiles in sickle cell disease. Acta Haematol 103 (2000) 197-202
18. Yuzbasiyan-Gurkan V.A., Brewer G.J., Vander A.J., Guenther M.J., and Prasad A. Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31 (1989) 87-90
19. Malave I., Perdomo Y., Escalona E., et al. Levels of tumor necrosis factor-α /cachectin (TNF alpha) in sera from patients with sickle cell disease. Acta Haematol 90 (1993) 172-176
20. Marwah S.S., Blann A.D., Rea C., Phillips J.D., Wright J., and Bareford D. Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis. Am J Hematol 69 (2002) 144-146
21. Prasad A.S., Bao B., Beck F.W., Kucuk O., and Sarkar F.H. Antioxidant effect of zinc in humans. Free Radic Biol Med 37 (2004) 1182-1190
22. Prasad A.S. Zinc: an overview. Nutrition 11 (1995) 93-99
23. Prasad A.S., Beck F.W., Bao B., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85 (2007) 837-844
24. Davis J.N., Kucuk O., Djuric Z., and Sarkar F.H. Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes. Free Radic Biol Med 30 (2001) 1293-1302
25. Prasad A.S., Diwany M., Gabr M., Sandstead H.H., Mokhtar N., and Hefny A.E. Biochemical studies in thalassemia. Ann Intern Med 62 (1965) 87-96
26. Dogru U., Arcasoy A., and Cavdar A.O. Zinc levels of plasma, erythrocyte, hair, and urine in homozygote beta thalassemia. Acta Haemat 62 (1979) 41
27. Arcsoy A., Cavdar A.O., Erlug H., and Gurpinar F. Zinc treatment in homozygous beta-Thalassemia (A preliminary study). In: Prasad A.S., Cavdar A.O., Brewer G.J., and Aggett P.J. (Eds). Zinc deficiency in human subjects (1983), Alan R. Liss, New York 107-116
28. Moafi A., Mobaraki G., Taheri S.S., Heidarzadeh A., Shahabi I., and Majidi F. Zinc in thalassemic patients and its relation with depression. Biol Trace Elem Res 123 (2008) 8-13
29. Prasad A.S., Fitzgerald J., Bao B., Beck F.W., and Chandrasekar P.H. Treatment of common cold with zinc acetate lozenges. Ann Int Med 133 (2000) 245-252
30. Shankar A.H., and Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68 (1998) 447S-463S
31. King L.E., Frentzel J.W., Mann J.J., and Fraker P.J. Chronic zinc deficiency in mice disrupted T cell lymphopoiesis and erythropoiesis while B cell lymphopoiesis and myelopoiesis were maintained. J Am Coll Nutr 24 (2005) 494-502
32. Liew C.W., Rand K.D., Simpson R.J., et al. Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1. J Biol Chem 281 (2006) 28296-28306
33. Cantor A.B., and Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21 (2002) 3368-3376
34. Wessely O., Deiner E.M., Beug H., and von Lindern M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J 16 (1997) 267-280
35. von Lindern M., Zauner W., Mellitzer G., et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94 (1999) 550-559
36. Leberbauer C., Boulmé F., Unfried G., Huber J., Beug H., and Müllner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 105 (2005) 85-94
37. Schnog J.B., Lard L.R., Rojer R.A., Van der Dijs F.P., Muskiet F.A., and Duits A.J. New concepts in assessing sickle cell disease severity. Am J Hematol 58 (1998) 61-66
38. Smolinski P.A., Offermann M.K., Eckman J.R., and Wick T.M. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: A potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 85 (1995) 2945-2950
39. Hebbel R.P., and Vercellotti G.M. The endothelial biology of sickle cell disease. J Lab Clin Med 129 (1997) 288-293
40. Solovey A., Gui L., Key N.S., and Hebbel R.P. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101 (1998) 1899-1904
41. Kuvibidila S.R., Sandoval M., Lao J., et al. Plasma zinc levels inversely correlate with vascular cell adhesion molecule-1 concentration in children with sickle cell disease. J Natl Med Assoc 98 (2006) 1263-1272
42. Wagner M.C., Eckman J.R., and Wick T.M. Sickle cell adhesion depends on hemodynamics and endothelial activation. J Lab Clin Med 144 (2004) 260-267
43. Castro L., and Freeman B.A. Reactive oxygen species in human health and disease. Nutrition 17 (2001) 161-165
44. Wood K.C., and Granger D.N. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin Exp Pharmacol Physiol 34 (2007) 926-932
45. Ceylan E., Aksoy N., Gencer M., Vural H., Keles H., and Selek S. Evaluation of oxidative-antioxidative status and the L-arginine-nitric oxide pathway in asthmatic patients. Respir Med 99 (2005) 871-876
46. Bettger W.J. Zinc and selenium, site-specific versus general antioxidant. Can. J. Physiol Pharmacol 71 (1993) 721-724
47. Hasanato R.M. Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia. Ann Saudi Med 26 (2006) 17-21
48. Lachance P.A., Nakat Z., and Jeong W. Antioxidants: an integrative approach. Nutrition 17 (2001) 835-838
49. Ozaki Y., Ohashi T., and Kume S. Potentiation of neutrophil function by recombinant DNA-produced interleukin-1α. J Leukocyte Biol 42 (1987) 621-627
50. Berkow R.L., Wang D., Larrick J.W., Dodson R.W., and Howard T.H. Enhancement of neutrophil superoxide production by pre-incubation with recombinant human tumor necrosis factor. J Immunol 139 (1987) 3783-3791
51. Prasad A.S., Beck F.W., Grabowski S.M., and Kaplan J. Zinc deficiency: changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects. Proc Assoc Am Physicians 109 (1997) 68-77
52. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
53. Prasad A.S., Brewer G.J., Schoonaker E.B., and Rabbani P. Hypocuprenuria induced by zinc therapy in adults. JAMA 240 (1978) 2166-2168